GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » Cash Conversion Cycle

Shanghai INT Medical Instruments Co (HKSE:01501) Cash Conversion Cycle : 155.42 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Shanghai INT Medical Instruments Co's Days Sales Outstanding for the six months ended in Dec. 2023 was 40.35.
Shanghai INT Medical Instruments Co's Days Inventory for the six months ended in Dec. 2023 was 147.26.
Shanghai INT Medical Instruments Co's Days Payable for the six months ended in Dec. 2023 was 32.19.
Therefore, Shanghai INT Medical Instruments Co's Cash Conversion Cycle (CCC) for the six months ended in Dec. 2023 was 155.42.


Shanghai INT Medical Instruments Co Cash Conversion Cycle Historical Data

The historical data trend for Shanghai INT Medical Instruments Co's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai INT Medical Instruments Co Cash Conversion Cycle Chart

Shanghai INT Medical Instruments Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial 105.49 114.26 140.13 185.90 172.87

Shanghai INT Medical Instruments Co Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 126.02 191.94 155.30 196.35 155.42

Competitive Comparison of Shanghai INT Medical Instruments Co's Cash Conversion Cycle

For the Medical Instruments & Supplies subindustry, Shanghai INT Medical Instruments Co's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai INT Medical Instruments Co's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai INT Medical Instruments Co's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Shanghai INT Medical Instruments Co's Cash Conversion Cycle falls into.



Shanghai INT Medical Instruments Co Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Shanghai INT Medical Instruments Co's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=47.46+165.99-40.58
=172.87

Shanghai INT Medical Instruments Co's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=40.35+147.26-32.19
=155.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai INT Medical Instruments Co  (HKSE:01501) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Shanghai INT Medical Instruments Co Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai INT Medical Instruments Co (HKSE:01501) Business Description

Traded in Other Exchanges
N/A
Address
No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803
Shanghai INT Medical Instruments Co Ltd formerly Shanghai Kindly Medical Instruments Co Ltd is a manufacturer of cardiovascular interventional devices, which are mainly used in cardiovascular surgeries, and in particular, PCI procedures in China. It is engaged in the sales, manufacture, research, and development of cardiovascular interventional medical devices as well as related accessories and molds. It is also engaged in the research and development of other interventional and implantable medical devices, such as neurological interventional medical devices and endocardia implantable medical devices, among others. Geographically, it has operations in Mainland China, Europe, the United States, and Other countries.

Shanghai INT Medical Instruments Co (HKSE:01501) Headlines

No Headlines